abstract |
The present invention relates to a vaccine against members of the genus metapneumovirus or RSV or a virus comprising a significant genetic homology in protein F to members of the genus metapneumovirus, whereby the vaccine is a live attenuated virus. In particular, the vaccine is directed against metapneumovirus of avian or human origin. |